Acute Biphenotypic Leukaemia (myeloid and Null-ALL Type) Supervening in a Myelodysplastic Syndrome
Overview
Authors
Affiliations
An acute leukaemia was seen in a 72-year-old patient with a myelodysplastic syndrome (MDS) of 14 months duration, who had been treated only with steroids. The morphological appearance of the blast cells suggested a poorly differentiated cell type. Surface marker analysis, including double staining studies, showed the coexistence of a population of null acute lymphoblastic leukaemia (ALL) blast cells together with acute myeloid leukaemia type cells. No chromosomal alterations were detected. The change from a chronic MDS to an acute leukaemia of mixed (myeloid and null ALL) type suggests either transformation of a pre-existing abnormal clone or de novo appearance of two separate leukaemic clones.
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia.
Martins F, Kruszewski M, Scarpelli I, Schoumans J, Spertini O, Lubbert M Ann Hematol. 2020; 100(1):63-78.
PMID: 32556451 DOI: 10.1007/s00277-020-04114-2.
Algarni A, Akhtari M, Fu K Case Rep Hematol. 2012; 2012:207537.
PMID: 22937321 PMC: 3420696. DOI: 10.1155/2012/207537.
Sato N, Nakazato T, Kizaki M, Ikeda Y, Okamoto S Int J Hematol. 2004; 79(2):147-51.
PMID: 15005342 DOI: 10.1532/ijh97.03137.
Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.
Layton D, Mufti G Blut. 1986; 53(6):423-36.
PMID: 3542084 DOI: 10.1007/BF00320305.
The nature of blast cells in myelodysplastic syndromes evolving to acute leukaemia.
San Miguel J, Gonzalez M, Canizo M, Anta J, Hernandez J, Ortega F Blut. 1986; 52(6):357-63.
PMID: 3459562 DOI: 10.1007/BF00320782.